These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Broad spectrum anti-coronavirus activity of a series of anti-malaria quinoline analogues. Persoons L; Vanderlinden E; Vangeel L; Wang X; Do NDT; Foo SC; Leyssen P; Neyts J; Jochmans D; Schols D; De Jonghe S Antiviral Res; 2021 Sep; 193():105127. PubMed ID: 34217752 [TBL] [Abstract][Full Text] [Related]
8. Stenoparib, an Inhibitor of Cellular Poly(ADP-Ribose) Polymerase, Blocks Replication of the SARS-CoV-2 and HCoV-NL63 Human Coronaviruses Stone NE; Jaramillo SA; Jones AN; Vazquez AJ; Martz M; Versluis LM; Raniere MO; Nunnally HE; Zarn KE; Nottingham R; Ng KR; Sahl JW; Wagner DM; Knudsen S; Settles EW; Keim P; French CT mBio; 2021 Jan; 12(1):. PubMed ID: 33468703 [TBL] [Abstract][Full Text] [Related]
9. Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506. Carbajo-Lozoya J; Müller MA; Kallies S; Thiel V; Drosten C; von Brunn A Virus Res; 2012 Apr; 165(1):112-7. PubMed ID: 22349148 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses. Adedeji AO; Singh K; Kassim A; Coleman CM; Elliott R; Weiss SR; Frieman MB; Sarafianos SG Antimicrob Agents Chemother; 2014 Aug; 58(8):4894-8. PubMed ID: 24841268 [TBL] [Abstract][Full Text] [Related]
11. Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model. de Wilde AH; Falzarano D; Zevenhoven-Dobbe JC; Beugeling C; Fett C; Martellaro C; Posthuma CC; Feldmann H; Perlman S; Snijder EJ Virus Res; 2017 Jan; 228():7-13. PubMed ID: 27840112 [TBL] [Abstract][Full Text] [Related]
12. Antiviral Activities of Halogenated Emodin Derivatives against Human Coronavirus NL63. Horvat M; Avbelj M; Durán-Alonso MB; Banjanac M; Petković H; Iskra J Molecules; 2021 Nov; 26(22):. PubMed ID: 34833917 [TBL] [Abstract][Full Text] [Related]
13. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion. Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418 [TBL] [Abstract][Full Text] [Related]
14. The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses. Martinez DR; Moreira FR; Catanzaro NJ; Diefenbacher MV; Zweigart MR; Gully KL; De la Cruz G; Brown AJ; Adams LE; Yount B; Baric TJ; Mallory ML; Conrad H; May SR; Dong S; Scobey DT; Nguyen C; Montgomery SA; Perry JK; Babusis D; Barrett KT; Nguyen AH; Nguyen AQ; Kalla R; Bannister R; Feng JY; Cihlar T; Baric RS; Mackman RL; Bilello JP; Schäfer A; Sheahan TP Sci Transl Med; 2024 May; 16(748):eadj4504. PubMed ID: 38776389 [TBL] [Abstract][Full Text] [Related]
15. A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses. Ahn DG; Yoon GY; Lee S; Ku KB; Kim C; Kim KD; Kwon YC; Kim GW; Kim BT; Kim SJ Viruses; 2021 Aug; 13(8):. PubMed ID: 34452503 [TBL] [Abstract][Full Text] [Related]
16. Flexibility as a Strategy in Nucleoside Antiviral Drug Design. Peters HL; Ku TC; Seley-Radtke KL Curr Med Chem; 2015; 22(34):3910-21. PubMed ID: 26282942 [TBL] [Abstract][Full Text] [Related]
17. Repurposing Nucleoside Analogs for Human Coronaviruses. Zandi K; Amblard F; Musall K; Downs-Bowen J; Kleinbard R; Oo A; Cao D; Liang B; Russell OO; McBrayer T; Bassit L; Kim B; Schinazi RF Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33122172 [TBL] [Abstract][Full Text] [Related]
18. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection. Dyall J; Coleman CM; Hart BJ; Venkataraman T; Holbrook MR; Kindrachuk J; Johnson RF; Olinger GG; Jahrling PB; Laidlaw M; Johansen LM; Lear-Rooney CM; Glass PJ; Hensley LE; Frieman MB Antimicrob Agents Chemother; 2014 Aug; 58(8):4885-93. PubMed ID: 24841273 [TBL] [Abstract][Full Text] [Related]
19. Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL Kumar V; Shin JS; Shie JJ; Ku KB; Kim C; Go YY; Huang KF; Kim M; Liang PH Antiviral Res; 2017 May; 141():101-106. PubMed ID: 28216367 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of human coronavirus NL63 infection at early stages of the replication cycle. Pyrc K; Bosch BJ; Berkhout B; Jebbink MF; Dijkman R; Rottier P; van der Hoek L Antimicrob Agents Chemother; 2006 Jun; 50(6):2000-8. PubMed ID: 16723558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]